Not a huge look back study, but suffice t to have a good measure of tumours found (including bad ones). Equally if not more importantly, none were missed.
good clinical utility shown. Keep ticking the boxes I guess.
I’d like to see some more movement in some of the clinics and medical institutions that are reviewing the CX bladder.
no movement on the outstanding monies either.
